{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T14:23:07Z","timestamp":1794579787175,"version":"4.9.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T00:00:00Z","timestamp":1699833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T00:00:00Z","timestamp":1699833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100013161","name":"Swiss Life Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013161","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100017295","name":"Holcim Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100017295","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008473","name":"Gebauer Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008473","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Swiss Heart Foundation","award":["FF19045"],"award-info":[{"award-number":["FF19045"]}],"id":[{"id":"https:\/\/ror.org\/01k789405","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100018872","name":"Italian Society of Arterial Hypertension","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100018872","id-type":"DOI","asserted-by":"crossref"}]},{"name":"H.H. Sheikh Khalifa bin Hamad Al Thani Foundation Assistant Professorship"},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"crossref","award":["310030_197557"],"award-info":[{"award-number":["310030_197557"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100012545","name":"Stiftung f\u00fcr wissenschaftliche Forschung","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012545","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012654","name":"Olga Mayenfisch Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012654","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Kurt und Senta-Hermann Stiftung"},{"DOI":"10.13039\/501100008464","name":"EMDO Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008464","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Schweizerische Diabetes-Stiftung"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Metabolic cardiomyopathy (MCM), characterized by intramyocardial lipid accumulation, drives the progression to heart failure with preserved ejection fraction (HFpEF). Although evidence suggests that the mammalian silent information regulator 1 (Sirt1) orchestrates myocardial lipid metabolism, it is unknown whether its exogenous administration could avoid MCM onset. We investigated whether chronic treatment with recombinant Sirt1 (rSirt1) could halt MCM progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      <jats:italic>db\/db<\/jats:italic>\n                      mice, an established model of MCM, were supplemented with intraperitoneal rSirt1 or vehicle for 4\u00a0weeks and compared with their\n                      <jats:italic>db\/<\/jats:italic>\n                      \u2009+\u2009heterozygous littermates. At the end of treatment, cardiac function was assessed by cardiac ultrasound and left ventricular samples were collected and processed for molecular analysis. Transcriptional changes were evaluated using a custom PCR array. Lipidomic analysis was performed by mass spectrometry. H9c2 cardiomyocytes exposed to hyperglycaemia and treated with rSirt1 were used as in vitro model of MCM to investigate the ability of rSirt1 to directly target cardiomyocytes and modulate malondialdehyde levels and caspase 3 activity. Myocardial samples from diabetic and nondiabetic patients were analysed to explore Sirt1 expression levels and signaling pathways.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      rSirt1 treatment restored cardiac Sirt1 levels and preserved cardiac performance by improving left ventricular ejection fraction, fractional shortening and diastolic function (E\/A ratio). In left ventricular samples from rSirt1-treated\n                      <jats:italic>db\/db<\/jats:italic>\n                      mice, rSirt1 modulated the cardiac lipidome: medium and long-chain triacylglycerols, long-chain triacylglycerols, and triacylglycerols containing only saturated fatty acids were reduced, while those containing docosahexaenoic acid were increased. Mechanistically, several genes involved in lipid trafficking, metabolism and inflammation, such as\n                      <jats:italic>Cd36<\/jats:italic>\n                      ,\n                      <jats:italic>Acox3<\/jats:italic>\n                      ,\n                      <jats:italic>Pparg<\/jats:italic>\n                      ,\n                      <jats:italic>Ncoa3<\/jats:italic>\n                      , and\n                      <jats:italic>Ppara<\/jats:italic>\n                      were downregulated by rSirt1 both in vitro and in vivo. In humans, reduced cardiac expression levels of Sirt1 were associated with higher intramyocardial triacylglycerols and PPARG-related genes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      In the\n                      <jats:italic>db\/db<\/jats:italic>\n                      mouse model of MCM, chronic exogenous rSirt1 supplementation rescued cardiac function. This was associated with a modulation of the myocardial lipidome and a downregulation of genes involved in lipid metabolism, trafficking, inflammation, and PPARG signaling. These findings were confirmed in the human diabetic myocardium. Treatments that increase Sirt1 levels may represent a promising strategy to prevent myocardial lipid abnormalities and MCM development.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s12933-023-02057-2","type":"journal-article","created":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T13:01:27Z","timestamp":1699880487000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Treatment with recombinant Sirt1 rewires the cardiac lipidome and rescues diabetes-related metabolic cardiomyopathy"],"prefix":"10.1186","volume":"22","author":[{"given":"Sarah","family":"Costantino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Mengozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srividya","family":"Velagapudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shafeeq Ahmed","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Era","family":"Gorica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Akhmedov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Mongelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola Riccardo","family":"Pugliese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Masi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostino","family":"Virdis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"H\u00fclsmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian Matthias","family":"Matter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Hornemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Melina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Ruschitzka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas Felix","family":"Luscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Paneni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,13]]},"reference":[{"issue":"12","key":"2057_CR1","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1007\/s00109-022-02269-1","volume":"100","author":"Z Chen","year":"2022","unstructured":"Chen Z, Jin ZX, Cai J, Li R, Deng KQ, Ji YX, et al. Energy substrate metabolism and oxidative stress in metabolic cardiomyopathy. J Mol Med (Berl). 2022;100(12):1721\u201339.","journal-title":"J Mol Med (Berl)"},{"issue":"7752","key":"2057_CR2","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41586-019-1100-z","volume":"568","author":"GG Schiattarella","year":"2019","unstructured":"Schiattarella GG, Altamirano F, Tong D, French KM, Villalobos E, Kim SY, et al. Nitrosative stress drives heart failure with preserved ejection fraction. Nature. 2019;568(7752):351\u20136.","journal-title":"Nature"},{"issue":"8","key":"2057_CR3","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1113\/JP270538","volume":"594","author":"S Costantino","year":"2016","unstructured":"Costantino S, Paneni F, Cosentino F. Ageing, metabolism and cardiovascular disease. J Physiol. 2016;594(8):2061\u201373.","journal-title":"J Physiol"},{"issue":"3","key":"2057_CR4","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.cmet.2023.02.003","volume":"35","author":"NWS Chew","year":"2023","unstructured":"Chew NWS, Ng CH, Tan DJH, Kong G, Lin C, Chin YH, et al. The global burden of metabolic disease: data from 2000 to 2019. Cell Metab. 2023;35(3):414-428.e413.","journal-title":"Cell Metab"},{"issue":"4","key":"2057_CR5","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1093\/cvr\/cvx012","volume":"113","author":"K Nishida","year":"2017","unstructured":"Nishida K, Otsu K. Inflammation and metabolic cardiomyopathy. Cardiovasc Res. 2017;113(4):389\u201398.","journal-title":"Cardiovasc Res"},{"issue":"5","key":"2057_CR6","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.jacc.2018.11.033","volume":"73","author":"K McHugh","year":"2019","unstructured":"McHugh K, DeVore AD, Wu J, Matsouaka RA, Fonarow GC, Heidenreich PA, et al. Heart failure with preserved ejection fraction and diabetes: JACC state-of-the-art review. J Am Coll Cardiol. 2019;73(5):602\u201311.","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"2057_CR7","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1093\/cvr\/cvab367","volume":"118","author":"N Suffee","year":"2022","unstructured":"Suffee N, Baptista E, Piquereau J, Ponnaiah M, Doisne N, Ichou F, et al. Impacts of a high-fat diet on the metabolic profile and the phenotype of atrial myocardium in mice. Cardiovasc Res. 2022;118(15):3126\u201339.","journal-title":"Cardiovasc Res"},{"issue":"12","key":"2057_CR8","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1093\/eurheartj\/ehy903","volume":"40","author":"S Costantino","year":"2019","unstructured":"Costantino S, Akhmedov A, Melina G, Mohammed SA, Othman A, Ambrosini S, et al. Obesity-induced activation of JunD promotes myocardial lipid accumulation and metabolic cardiomyopathy. Eur Heart J. 2019;40(12):997\u20131008.","journal-title":"Eur Heart J"},{"key":"2057_CR9","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.biopha.2017.03.056","volume":"90","author":"H Karbasforooshan","year":"2017","unstructured":"Karbasforooshan H, Karimi G. The role of SIRT1 in diabetic cardiomyopathy. Biomed Pharmacother. 2017;90:386\u201392.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"2057_CR10","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","volume":"122","author":"G Jia","year":"2018","unstructured":"Jia G, Hill MA, Sowers JR. Diabetic cardiomyopathy. Circ Res. 2018;122(4):624\u201338.","journal-title":"Circ Res"},{"issue":"9","key":"2057_CR11","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41569-020-0339-2","volume":"17","author":"Y Tan","year":"2020","unstructured":"Tan Y, Zhang Z, Zheng C, Wintergerst KA, Keller BB, Cai L. Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence. Nat Rev Cardiol. 2020;17(9):585\u2013607.","journal-title":"Nat Rev Cardiol"},{"key":"2057_CR12","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.118.312498","author":"AE Kane","year":"2018","unstructured":"Kane AE, Sinclair DA. Sirtuins and NAD + in the development and treatment of metabolic and cardiovascular diseases. Circ Res. 2018. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.312498.","journal-title":"Circ Res"},{"issue":"6","key":"2057_CR13","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1161\/CIRCRESAHA.122.320888","volume":"131","author":"A Mengozzi","year":"2022","unstructured":"Mengozzi A, Costantino S, Paneni F, Duranti E, Nannipieri M, Mancini R, et al. Targeting SIRT1 rescues age- and obesity-induced microvascular dysfunction in ex-vivo human vessels. Circ Res. 2022;131(6):476\u201391.","journal-title":"Circ Res"},{"issue":"48","key":"2057_CR14","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1093\/eurheartj\/ehv290","volume":"36","author":"S Winnik","year":"2015","unstructured":"Winnik S, Auwerx J, Sinclair DA, Matter CM. Protective effects of sirtuins in cardiovascular diseases: from bench to bedside. Eur Heart J. 2015;36(48):3404\u201312.","journal-title":"Eur Heart J"},{"issue":"7","key":"2057_CR15","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nrendo.2009.101","volume":"5","author":"F Liang","year":"2009","unstructured":"Liang F, Kume S, Koya D. SIRT1 and insulin resistance. Nat Rev Endocrinol. 2009;5(7):367\u201373.","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"2057_CR16","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1053\/j.gastro.2013.10.059","volume":"146","author":"Y Li","year":"2014","unstructured":"Li Y, Wong K, Giles A, Jiang J, Lee JW, Adams AC, et al. Hepatic SIRT1 attenuates hepatic steatosis and controls energy balance in mice by inducing fibroblast growth factor 21. Gastroenterology. 2014;146(2):539-549.e537.","journal-title":"Gastroenterology"},{"issue":"2","key":"2057_CR17","doi-asserted-by":"publisher","first-page":"996","DOI":"10.3390\/ijms23020996","volume":"23","author":"T Yamamoto","year":"2022","unstructured":"Yamamoto T, Sano M. Deranged myocardial fatty acid metabolism in heart failure. Int J Mol Sci. 2022;23(2):996.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2057_CR18","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","volume":"62","author":"WJ Paulus","year":"2013","unstructured":"Paulus WJ, Tsch\u00f6pe C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol. 2013;62(4):263\u201371.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"2057_CR19","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.120.007197","volume":"13","author":"M Packer","year":"2020","unstructured":"Packer M. Cardioprotective effects of sirtuin-1 and its downstream effectors: potential role in mediating the heart failure benefits of SGLT2 (Sodium-Glucose Cotransporter 2) inhibitors. Circ Heart Fail. 2020;13(9): e007197.","journal-title":"Circ Heart Fail"},{"key":"2057_CR20","doi-asserted-by":"publisher","first-page":"755060","DOI":"10.3389\/fphys.2021.755060","volume":"12","author":"YJ Wang","year":"2021","unstructured":"Wang YJ, Paneni F, Stein S, Matter CM. Modulating sirtuin biology and nicotinamide adenine diphosphate metabolism in cardiovascular disease-from bench to bedside. Front Physiol. 2021;12:755060.","journal-title":"Front Physiol"},{"key":"2057_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.106014","volume":"175","author":"MP Jalgaonkar","year":"2022","unstructured":"Jalgaonkar MP, Parmar UM, Kulkarni YA, Oza MJ. SIRT1-FOXOs activity regulates diabetic complications. Pharmacol Res. 2022;175: 106014.","journal-title":"Pharmacol Res"},{"issue":"13","key":"2057_CR22","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1093\/eurheartj\/ehu179","volume":"36","author":"F Paneni","year":"2015","unstructured":"Paneni F, Costantino S, Castello L, Battista R, Capretti G, Chiandotto S, et al. Targeting prolyl-isomerase Pin1 prevents mitochondrial oxidative stress and vascular dysfunction: insights in patients with diabetes. Eur Heart J. 2015;36(13):817\u201328.","journal-title":"Eur Heart J"},{"issue":"30","key":"2057_CR23","doi-asserted-by":"publisher","first-page":"7937","DOI":"10.1007\/s00216-014-8255-0","volume":"406","author":"RM Pellegrino","year":"2014","unstructured":"Pellegrino RM, Di Veroli A, Valeri A, Goracci L, Cruciani G. LC\/MS lipid profiling from human serum: a new method for global lipid extraction. Anal Bioanal Chem. 2014;406(30):7937\u201348.","journal-title":"Anal Bioanal Chem"},{"key":"2057_CR24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.chroma.2016.02.054","volume":"1440","author":"M Narvaez-Rivas","year":"2016","unstructured":"Narvaez-Rivas M, Zhang Q. Comprehensive untargeted lipidomic analysis using core-shell C30 particle column and high field orbitrap mass spectrometer. J Chromatogr A. 2016;1440:123\u201334.","journal-title":"J Chromatogr A"},{"issue":"Suppl 1","key":"2057_CR25","first-page":"S13","volume":"41","author":"Classification and Diagnosis of Diabetes","year":"2018","unstructured":"Classification and Diagnosis of Diabetes. Standards of medical care in diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S13-s27.","journal-title":"Diabetes Care"},{"issue":"3","key":"2057_CR26","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41419-020-2367-6","volume":"11","author":"SK Yadav","year":"2020","unstructured":"Yadav SK, Kambis TN, Kar S, Park SY, Mishra PK. MMP9 mediates acute hyperglycemia-induced human cardiac stem cell death by upregulating apoptosis and pyroptosis in vitro. Cell Death Dis. 2020;11(3):186.","journal-title":"Cell Death Dis"},{"key":"2057_CR27","doi-asserted-by":"publisher","first-page":"6372430","DOI":"10.1155\/2021\/6372430","volume":"2021","author":"W Wang","year":"2021","unstructured":"Wang W, Gu H, Li W, Lin Y, Yao X, Luo W, et al. SRC-3 knockout attenuates myocardial injury induced by chronic intermittent hypoxia in mice. Oxid Med Cell Longev. 2021;2021:6372430.","journal-title":"Oxid Med Cell Longev"},{"issue":"3","key":"2057_CR28","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.cell.2012.06.027","volume":"150","author":"L Qiang","year":"2012","unstructured":"Qiang L, Wang L, Kon N, Zhao W, Lee S, Zhang Y, et al. Brown remodeling of white adipose tissue by SirT1-dependent deacetylation of Ppar\u03b3. Cell. 2012;150(3):620\u201332.","journal-title":"Cell"},{"key":"2057_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.742178","volume":"8","author":"FA Wenzl","year":"2021","unstructured":"Wenzl FA, Ambrosini S, Mohammed SA, Kraler S, L\u00fcscher TF, Costantino S, et al. Inflammation in metabolic cardiomyopathy. Front Cardiovasc Med. 2021;8: 742178.","journal-title":"Front Cardiovasc Med"},{"issue":"11","key":"2057_CR30","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1161\/CIRCRESAHA.120.315899","volume":"126","author":"LR Peterson","year":"2020","unstructured":"Peterson LR, Gropler RJ. Metabolic and molecular imaging of the diabetic cardiomyopathy. Circ Res. 2020;126(11):1628\u201345.","journal-title":"Circ Res"},{"key":"2057_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvaa217","author":"GG Schiattarella","year":"2020","unstructured":"Schiattarella GG, Rodolico D, Hill JA. Metabolic inflammation in heart failure with preserved ejection fraction. Cardiovasc Res. 2020. https:\/\/doi.org\/10.1093\/cvr\/cvaa217.","journal-title":"Cardiovasc Res"},{"issue":"18","key":"2057_CR32","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1016\/j.jacc.2023.01.049","volume":"81","author":"BA Borlaug","year":"2023","unstructured":"Borlaug BA, Sharma K, Shah SJ, Ho JE. Heart failure with preserved ejection fraction: JACC scientific statement. J Am Coll Cardiol. 2023;81(18):1810\u201334.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"2057_CR33","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1161\/CIRCRESAHA.118.313865","volume":"124","author":"PA Gorski","year":"2019","unstructured":"Gorski PA, Jang SP, Jeong D, Lee A, Lee P, Oh JG, et al. Role of SIRT1 in modulating acetylation of the sarco-endoplasmic reticulum Ca(2+)-ATPase in heart failure. Circ Res. 2019;124(9):e63\u201380.","journal-title":"Circ Res"},{"issue":"4","key":"2057_CR34","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.yjmcc.2012.07.019","volume":"53","author":"A Planavila","year":"2012","unstructured":"Planavila A, Dominguez E, Navarro M, Vinciguerra M, Iglesias R, Giralt M, et al. Dilated cardiomyopathy and mitochondrial dysfunction in Sirt1-deficient mice: a role for Sirt1-Mef2 in adult heart. J Mol Cell Cardiol. 2012;53(4):521\u201331.","journal-title":"J Mol Cell Cardiol"},{"key":"2057_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/ph15111337","author":"R Vilella","year":"2022","unstructured":"Vilella R, Izzo S, Naponelli V, Savi M, Bocchi L, Dallabona C, et al. In vivo treatment with a standardized green tea extract restores cardiomyocyte contractility in diabetic rats by improving mitochondrial function through SIRT1 activation. Pharmaceuticals (Basel). 2022. https:\/\/doi.org\/10.3390\/ph15111337.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"21","key":"2057_CR36","doi-asserted-by":"publisher","first-page":"12355","DOI":"10.1111\/jcmm.15725","volume":"24","author":"BC Ren","year":"2020","unstructured":"Ren BC, Zhang YF, Liu SS, Cheng XJ, Yang X, Cui XG, et al. Curcumin alleviates oxidative stress and inhibits apoptosis in diabetic cardiomyopathy via Sirt1-Foxo1 and PI3K-Akt signalling pathways. J Cell Mol Med. 2020;24(21):12355\u201367.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"2057_CR37","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1021\/jacs.0c10836","volume":"143","author":"Q Huang","year":"2021","unstructured":"Huang Q, Su H, Qi B, Wang Y, Yan K, Wang X, et al. A SIRT1 activator, ginsenoside Rc, promotes energy metabolism in cardiomyocytes and neurons. J Am Chem Soc. 2021;143(3):1416\u201327.","journal-title":"J Am Chem Soc"},{"issue":"1","key":"2057_CR38","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12933-018-0754-4","volume":"17","author":"M Waldman","year":"2018","unstructured":"Waldman M, Cohen K, Yadin D, Nudelman V, Gorfil D, Laniado-Schwartzman M, et al. Regulation of diabetic cardiomyopathy by caloric restriction is mediated by intracellular signaling pathways involving \u201cSIRT1 and PGC-1\u03b1.\u201d Cardiovasc Diabetol. 2018;17(1):111.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2057_CR39","doi-asserted-by":"publisher","first-page":"38186","DOI":"10.1038\/srep38186","volume":"6","author":"X Hou","year":"2016","unstructured":"Hou X, Rooklin D, Fang H, Zhang Y. Resveratrol serves as a protein-substrate interaction stabilizer in human SIRT1 activation. Sci Rep. 2016;6(1):38186.","journal-title":"Sci Rep"},{"issue":"3","key":"2057_CR40","doi-asserted-by":"publisher","first-page":"H833","DOI":"10.1152\/ajpheart.00418.2009","volume":"298","author":"M Sulaiman","year":"2010","unstructured":"Sulaiman M, Matta MJ, Sunderesan NR, Gupta MP, Periasamy M, Gupta M. Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol. 2010;298(3):H833-843.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"2057_CR41","doi-asserted-by":"publisher","first-page":"323","DOI":"10.4238\/2014.January.17.17","volume":"13","author":"XS Gu","year":"2014","unstructured":"Gu XS, Wang ZB, Ye Z, Lei JP, Li L, Su DF, et al. Resveratrol, an activator of SIRT1, upregulates AMPK and improves cardiac function in heart failure. Genet Mol Res. 2014;13(1):323\u201335.","journal-title":"Genet Mol Res"},{"issue":"4","key":"2057_CR42","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1152\/physrev.00030.2020","volume":"101","author":"J Ren","year":"2021","unstructured":"Ren J, Wu NN, Wang S, Sowers JR, Zhang Y. Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications. Physiol Rev. 2021;101(4):1745\u2013807.","journal-title":"Physiol Rev"},{"key":"2057_CR43","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ijcard.2020.07.017","volume":"320","author":"E Bj\u00f6rnson","year":"2020","unstructured":"Bj\u00f6rnson E, \u00d6stlund Y, St\u00e5hlman M, Adiels M, Omerovic E, Jeppsson A, et al. Lipid profiling of human diabetic myocardium reveals differences in triglyceride fatty acyl chain length and degree of saturation. Int J Cardiol. 2020;320:106\u201311.","journal-title":"Int J Cardiol"},{"issue":"12","key":"2057_CR44","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.jacc.2008.04.068","volume":"52","author":"S Hammer","year":"2008","unstructured":"Hammer S, Snel M, Lamb HJ, Jazet IM, van der Meer RW, Pijl H, et al. Prolonged caloric restriction in obese patients with type 2 diabetes mellitus decreases myocardial triglyceride content and improves myocardial function. J Am Coll Cardiol. 2008;52(12):1006\u201312.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"2057_CR45","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1161\/ATVBAHA.119.313286","volume":"40","author":"RP Mason","year":"2020","unstructured":"Mason RP, Libby P, Bhatt DL. Emerging mechanisms of cardiovascular protection for the omega-3 fatty acid eicosapentaenoic acid. Arterioscler Thromb Vasc Biol. 2020;40(5):1135\u201347.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2057_CR46","doi-asserted-by":"publisher","first-page":"1509421","DOI":"10.1155\/2022\/1509421","volume":"2022","author":"Y Shi","year":"2022","unstructured":"Shi Y, Li H, Wu T, Wang Q, Zhu Q, Guan X, et al. Docosahexaenoic acid-enhanced autophagic flux improves cardiac dysfunction after myocardial infarction by targeting the AMPK\/mTOR signaling pathway. Oxid Med Cell Longev. 2022;2022:1509421.","journal-title":"Oxid Med Cell Longev"},{"issue":"21","key":"2057_CR47","doi-asserted-by":"publisher","first-page":"4242","DOI":"10.1111\/febs.13418","volume":"282","author":"S Tucci","year":"2015","unstructured":"Tucci S, Behringer S, Spiekerkoetter U. De novo fatty acid biosynthesis and elongation in very long-chain acyl-CoA dehydrogenase-deficient mice supplemented with odd or even medium-chain fatty acids. FEBS J. 2015;282(21):4242\u201353.","journal-title":"FEBS J"},{"issue":"1","key":"2057_CR48","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12933-020-01188-0","volume":"20","author":"L Wang","year":"2021","unstructured":"Wang L, Cai Y, Jian L, Cheung CW, Zhang L, Xia Z. Impact of peroxisome proliferator-activated receptor-\u03b1 on diabetic cardiomyopathy. Cardiovasc Diabetol. 2021;20(1):2.","journal-title":"Cardiovasc Diabetol"},{"issue":"12","key":"2057_CR49","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1161\/CIRCRESAHA.119.314898","volume":"125","author":"H Li","year":"2019","unstructured":"Li H, Fan J, Zhao Y, Zhang X, Dai B, Zhan J, et al. Nuclear miR-320 mediates diabetes-induced cardiac dysfunction by activating transcription of fatty acid metabolic genes to cause lipotoxicity in the heart. Circ Res. 2019;125(12):1106\u201320.","journal-title":"Circ Res"},{"key":"2057_CR50","doi-asserted-by":"publisher","first-page":"120371","DOI":"10.1016\/j.lfs.2022.120371","volume":"294","author":"Y Li","year":"2022","unstructured":"Li Y, Yang M, Tan J, Shen C, Deng S, Fu X, et al. Targeting ACSL1 promotes cardiomyocyte proliferation and cardiac regeneration. Life Sci. 2022;294:120371.","journal-title":"Life Sci"},{"issue":"1","key":"2057_CR51","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1161\/CIRCRESAHA.117.311307","volume":"122","author":"K Tsushima","year":"2018","unstructured":"Tsushima K, Bugger H, Wende AR, Soto J, Jenson GA, Tor AR, et al. Mitochondrial reactive oxygen species in lipotoxic hearts induce post-translational modifications of AKAP121, DRP1, and OPA1 that promote mitochondrial fission. Circ Res. 2018;122(1):58\u201373.","journal-title":"Circ Res"},{"key":"2057_CR52","doi-asserted-by":"publisher","DOI":"10.2337\/dc23-S002","author":"NA ElSayed","year":"2023","unstructured":"ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. 2. Classification and diagnosis of diabetes: standards of care in diabetes-2023. Diabet Care. 2023. https:\/\/doi.org\/10.2337\/dc23-S002.","journal-title":"Diabet Care"},{"issue":"1","key":"2057_CR53","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12974-021-02250-8","volume":"18","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Zhang J, Zheng Y, Zhang Y, Zhang XJ, Wang H, et al. NAD(+) improves cognitive function and reduces neuroinflammation by ameliorating mitochondrial damage and decreasing ROS production in chronic cerebral hypoperfusion models through Sirt1\/PGC-1\u03b1 pathway. J Neuroinflammation. 2021;18(1):207.","journal-title":"J Neuroinflammation"},{"issue":"21","key":"2057_CR54","doi-asserted-by":"publisher","first-page":"7458","DOI":"10.1093\/nar\/gkq609","volume":"38","author":"L Han","year":"2010","unstructured":"Han L, Zhou R, Niu J, McNutt MA, Wang P, Tong T. SIRT1 is regulated by a PPAR{\u03b3}-SIRT1 negative feedback loop associated with senescence. Nucleic Acids Res. 2010;38(21):7458\u201371.","journal-title":"Nucleic Acids Res"},{"issue":"7170","key":"2057_CR55","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/nature06261","volume":"450","author":"JC Milne","year":"2007","unstructured":"Milne JC, Lambert PD, Schenk S, Carney DP, Smith JJ, Gagne DJ, et al. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature. 2007;450(7170):712\u20136.","journal-title":"Nature"},{"key":"2057_CR56","doi-asserted-by":"publisher","first-page":"634900","DOI":"10.3389\/fcell.2021.634900","volume":"9","author":"W Jia","year":"2021","unstructured":"Jia W, Bai T, Zeng J, Niu Z, Fan D, Xu X, et al. Combined administration of metformin and atorvastatin attenuates diabetic cardiomyopathy by inhibiting inflammation, apoptosis, and oxidative stress in type 2 diabetic mice. Front Cell Dev Biol. 2021;9:634900.","journal-title":"Front Cell Dev Biol"},{"key":"2057_CR57","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00377.2014","author":"LB Gano","year":"2014","unstructured":"Gano LB, Donato AJ, Pasha HM, Hearon CM, Sindler AL, Seals DR. The SIRT1 activator SRT1720 reverses vascular endothelial dysfunction, excessive superoxide production, and inflammation with aging in mice. Am J Physiol Heart Circ Physiol. 2014. https:\/\/doi.org\/10.1152\/ajpheart.00377.2014.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"12","key":"2057_CR58","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1093\/cvr\/cvad102","volume":"119","author":"K Yang","year":"2023","unstructured":"Yang K, Velagapudi S, Akhmedov A, Kraler S, Lapikova-Bryhinska T, Schmiady MO, et al. Chronic SIRT1 supplementation in diabetic mice improves endothelial function by suppressing oxidative stress. Cardiovasc Res. 2023;119(12):2190\u2013201.","journal-title":"Cardiovasc Res"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-02057-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-023-02057-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-02057-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T13:02:45Z","timestamp":1699880565000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-023-02057-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,13]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2057"],"URL":"https:\/\/doi.org\/10.1186\/s12933-023-02057-2","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,13]]},"assertion":[{"value":"19 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal experiments were carried out in accordance with our institutional guidelines and were approved by the Canton Z\u00fcrich veterinary authorities. The study protocol for human samples\u2019 collection and processing was approved by the Local Ethics Committee, and in accordance with institutional guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"T.F.L. has outside this work received research and educational grants to the institution Abbott, Amgen, AstraZeneca, Boehringer-Ingelheim, Daichi-Sankyo, Menarini Foundation, Novartis, Novo Nordisk, Roche Diagnostics, Sanofi and Vifor and honoraria from Amgen, Dacadoo, Daichi-Sankyo, Menarini Foundation, Novartis, Novo Nordisk, Philips and Pfizer. F.R. has not received personal payments from pharmaceutical companies or device manufacturers in the last three years (remuneration for the time spent in activities, such as participation as steering committee member of clinical trials and member of the Pfizer Research Award selection committee in Switzerland, were made directly to the University of Zurich). The Department of Cardiology (University Hospital of Zurich\/University of Zurich) reports research-, educational- and\/or travel grants from Abbott, Amgen, Astra Zeneca, Bayer, Berlin Heart, B. Braun, Biosense Webster, Biosensors Europe AG, Biotronik, BMS, Boehringer Ingelheim, Boston Scientific, Bracco, Cardinal Health Switzerland, Corteria, Daiichi, Diatools AG, Edwards Lifesciences, Guidant Europe NV (BS), Hamilton Health Sciences, Kaneka Corporation, Kantar, Labormedizinisches Zentrum, Medtronic, MSD, Mundipharma Medical Company, Novartis, Novo Nordisk, Orion, Pfizer, Quintiles Switzerland Sarl, Sahajanand IN, Sanofi, Sarstedt AG, Servier, SIS Medical, SSS International Clinical Research, Terumo Deutschland, Trama Solutions, V-Wave, Vascular Medical, Vifor, Wissens Plus, ZOLL. The research and educational grants do not impact F.R.\u2019s personal remuneration. F.P. has received personal fees from Novo Nordisk and is a scientific consultant for Vectura Pharma.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"312"}}